C/EBPβ: The structure, regulation, and its roles in inflammation-related diseases

Biomed Pharmacother. 2023 Dec 31:169:115938. doi: 10.1016/j.biopha.2023.115938. Epub 2023 Nov 24.

Abstract

Inflammation, a mechanism of the human body, has been implicated in many diseases. Inflammatory responses include the release of inflammatory mediators by activating various signaling pathways. CCAAT/enhancer binding protein β (C/EBPβ), a transcription factor in the C/EBP family, contains the leucine zipper (bZIP) domain. The expression of C/EBPβ is mediated at the transcriptional and post-translational levels, such as phosphorylation, acetylation, methylation, and SUMOylation. C/EBPβ has been involved in inflammatory responses by mediating several signaling pathways, such as MAPK/NF-κB and IL-6/JAK/STAT3 pathways. C/EBPβ plays an important role in the pathological development of inflammation-related diseases, such as osteoarthritis, pneumonia, hepatitis, inflammatory bowel diseases, and rheumatoid arthritis. Here, we comprehensively discuss the structure and biological effects of C/EBPβ and its role in inflammatory diseases.

Keywords: C/EBPβ; Hepatitis; Inflammation; Inflammatory bowel diseases; Osteoarthritis.

Publication types

  • Review

MeSH terms

  • Gene Expression Regulation*
  • Humans
  • Inflammation
  • NF-kappa B* / metabolism
  • Phosphorylation
  • Signal Transduction

Substances

  • NF-kappa B